| Brian A Tansky, MD | |
|
1650 Cowles St, Fairbanks, AK 99701-5925 | |
| (907) 458-5556 | |
| Not Available |
| Full Name | Brian A Tansky |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine - Emergency Medical Services |
| Location | 1650 Cowles St, Fairbanks, Alaska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841287273 | NPI | - | NPPES |
| MD5589 | Medicaid | AK | |
| MD55891 | Medicaid | AK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207PE0004X | Emergency Medicine - Emergency Medical Services | 4511 (Alaska) | Primary |
| Entity Name | Golden Heart Emergency Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649469446 PECOS PAC ID: 1658461892 Enrollment ID: O20071212000298 |
News Archive
Nabriva Therapeutics AG, a biotechnology company focused on developing pleuromutilins, a new class of antibiotics for the treatment of serious infections caused by resistant Gram-positive and Gram-negative pathogens, announced today that the United States Food and Drug Administration has granted Qualified Infectious Disease Product (QIDP) as well as Fast Track status designation to Nabriva's lead product lefamulin, for the treatment of community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI).
New imaging technologies are enabling doctors to not only diagnose a variety of orthopaedic and musculoskeletal conditions with more accuracy, but also to determine with unprecedented precision whether clinical recovery from bone, joint or tendon damage is actually complete and not simply a "placebo effect."
Scientists at The Scripps Research Institute (TSRI) have published one of the first laboratory studies of MDPV, an emerging recreational drug that has been sold as "bath salts." The TSRI researchers confirmed the drug's powerful stimulant effects in rats and found evidence that it could be more addictive than methamphetamine, one of the most addictive substances to date.
It is estimated that over a third of the new cancer cases expected to occur in the U.S. in 2013 will be related to overweight or obesity, physical inactivity, and poor nutrition. Thanks to the work of one NYU Steinhardt researcher, we may better understand why.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brian A Tansky, MD Po Box 55289, North Pole, AK 99705-0289 Ph: (907) 488-1425 | Brian A Tansky, MD 1650 Cowles St, Fairbanks, AK 99701-5925 Ph: (907) 458-5556 |
News Archive
Nabriva Therapeutics AG, a biotechnology company focused on developing pleuromutilins, a new class of antibiotics for the treatment of serious infections caused by resistant Gram-positive and Gram-negative pathogens, announced today that the United States Food and Drug Administration has granted Qualified Infectious Disease Product (QIDP) as well as Fast Track status designation to Nabriva's lead product lefamulin, for the treatment of community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI).
New imaging technologies are enabling doctors to not only diagnose a variety of orthopaedic and musculoskeletal conditions with more accuracy, but also to determine with unprecedented precision whether clinical recovery from bone, joint or tendon damage is actually complete and not simply a "placebo effect."
Scientists at The Scripps Research Institute (TSRI) have published one of the first laboratory studies of MDPV, an emerging recreational drug that has been sold as "bath salts." The TSRI researchers confirmed the drug's powerful stimulant effects in rats and found evidence that it could be more addictive than methamphetamine, one of the most addictive substances to date.
It is estimated that over a third of the new cancer cases expected to occur in the U.S. in 2013 will be related to overweight or obesity, physical inactivity, and poor nutrition. Thanks to the work of one NYU Steinhardt researcher, we may better understand why.
› Verified 8 days ago
Mark O Simon, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1650 Cowles St, Fairbanks, AK 99701 Phone: 907-458-5556 | |
Dr. Stephen S Gerrish, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1408 19th Ave, Tanana Chiefs Conference, Fairbanks, AK 99701 Phone: 907-451-6682 Fax: 907-459-3811 | |
Dr. Caroline Elizabeth Timmerman, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1650 Cowles St, Fairbanks, AK 99701 Phone: 907-458-5555 | |
Carol J Phillips, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1650 Cowles St, Fairbanks, AK 99701 Phone: 907-458-5555 | |
John Browning Bass, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4076 Neely Rd, Fairbanks, AK 99703 Phone: 907-361-5172 | |
Dr. Leonie Horster Deramus, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1867 Airport Way, Ste 130b, Fairbanks, AK 99701 Phone: 907-452-2178 Fax: 907-452-3524 | |
Art J Strauss, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1650 Cowles St, Fairbanks, Fairbanks, AK 99701 Phone: 907-458-5555 |